Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Treasury Shares (2022 - 2024)

Historic Treasury Shares for Centessa Pharmaceuticals (CNTA) over the last 3 years, with Q4 2024 value amounting to $1.5 million.

  • Centessa Pharmaceuticals' Treasury Shares fell 2253.88% to $1.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.5 million, marking a year-over-year decrease of 2253.88%. This contributed to the annual value of $1.5 million for FY2024, which is 2253.88% down from last year.
  • Per Centessa Pharmaceuticals' latest filing, its Treasury Shares stood at $1.5 million for Q4 2024, which was down 2253.88% from $2.4 million recorded in Q1 2024.
  • Centessa Pharmaceuticals' 5-year Treasury Shares high stood at $2.7 million for Q1 2023, and its period low was $715432.0 during Q2 2022.
  • Moreover, its 3-year median value for Treasury Shares was $2.1 million (2023), whereas its average is $1.9 million.
  • Its Treasury Shares has fluctuated over the past 5 years, first soared by 24528.15% in 2023, then plummeted by 2253.88% in 2024.
  • Over the past 3 years, Centessa Pharmaceuticals' Treasury Shares (Quarter) stood at $1.8 million in 2022, then rose by 8.02% to $1.9 million in 2023, then dropped by 22.54% to $1.5 million in 2024.
  • Its last three reported values are $1.5 million in Q4 2024, $2.4 million for Q1 2024, and $1.9 million during Q4 2023.